Amyloidosis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
A tissue [[biopsy]] or fat [[aspirate]] should be done to confirm the presence or type of [[amyloid]] protein which is involved in the [[pathogenesis]] of the disease. | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Latest revision as of 19:30, 2 January 2019
|
Amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Amyloidosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Amyloidosis other diagnostic studies |
|
Risk calculators and risk factors for Amyloidosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
A tissue biopsy or fat aspirate should be done to confirm the presence or type of amyloid protein which is involved in the pathogenesis of the disease.
Other Diagnostic Studies
- A tissue biopsy or fat aspirate should be done to confirm the presence or type of amyloid protein which is involved in the pathogenesis of the disease.[1]
References
- ↑ Mahmood S, Palladini G, Sanchorawala V, Wechalekar A (February 2014). "Update on treatment of light chain amyloidosis". Haematologica. 99 (2): 209–21. doi:10.3324/haematol.2013.087619. PMC 3912950. PMID 24497558.